{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,8]],"date-time":"2024-09-08T02:14:53Z","timestamp":1725761693852},"publisher-location":"Boston, MA","reference-count":26,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781489953414"},{"type":"electronic","value":"9781489953391"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1990]]},"DOI":"10.1007\/978-1-4899-5339-1_19","type":"book-chapter","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T15:19:50Z","timestamp":1386256790000},"page":"273-282","source":"Crossref","is-referenced-by-count":3,"title":["Comparison of the Clinical Courses in Patients with Juvenile Neuronal Ceroid Lipofuscinosis Receiving Antioxidant Treatment and Those without Antioxidant Treatment"],"prefix":"10.1007","author":[{"given":"P.","family":"Santavuori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Heiskala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Autti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Westermarck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"Suppl","key":"19_CR1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/ajmg.1320310630","volume":"5","author":"MJ Bennet","year":"1988","unstructured":"Bennet MJ, Hosking GP, Gayton R, Thompson G, Galloway JH, Cartwright IJ (1988): Therapeutic modification of membrane lipid abnormalities in juvenile neuronal ceroid-lipofuscinosis (Batten disease). Am J Med Genet, Suppl 5: 275\u2013284.","journal-title":"Am J Med Genet"},{"key":"19_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1469-8749.1986.tb03940.x","volume":"28","author":"MJ Bennet","year":"1986","unstructured":"Bennet MJ, Gillis WS, Hosking GP, Galloway JH, Cartwright IJ (1986): Lipid abnormalities in serum in Batten\u2019s disease. Dev Med Child Neurol 28: 815\u2013817.","journal-title":"Dev Med Child Neurol"},{"key":"19_CR3","first-page":"5","volume-title":"Clinical classification of neuronal ceroid-lipofuscinosis subtypes","author":"RMN Boustany","year":"1988","unstructured":"Boustany RMN, Alroy J, Kolodny EH (1988): Clinical classification of neuronal ceroid-lipofuscinosis subtypes. Am J Med Genet, Suppl 5: 47\u201358."},{"issue":"1","key":"19_CR4","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/S0006-291X(87)80116-X","volume":"147","author":"G Dawson","year":"1987","unstructured":"Dawson G, Glaser P (1987): Apparent cathepsin B deficiency in neuronal ceroid lipofuscinosis can be explained by peroxide inhibition. Biochem Biophys Res Commun 147 (1): 267\u2013274.","journal-title":"Biochem Biophys Res Commun"},{"key":"19_CR5","first-page":"5","volume-title":"Abnormal cathepsin B activity in Batten disease","author":"G Dawson","year":"1988","unstructured":"Dawson G, Glaser PT (1988): Abnormal cathepsin B activity in Batten disease. Am J Med Genet, Suppl 5: 209\u2013220."},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0920-5632(88)90016-3","volume":"5","author":"PR Dyken","year":"1988","unstructured":"Dyken PR (1988): Reconsideration of the classification of the neuronal ceroid-lipofuscinoses. Am J Med Genet, Suppl 5: 69\u201384.","journal-title":"Suppl"},{"key":"19_CR7","first-page":"5","volume-title":"Accumulation of dolichol-linked oligosaccharides in ceroid-lipofuscinosis (Batten disease)","author":"NA Hall","year":"1988","unstructured":"Hall NA, Patrick AD (1988): Accumulation of dolichol-linked oligosaccharides in ceroid-lipofuscinosis (Batten disease). Am J Med Genet, Suppl 5: 221\u2013232."},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2190001","volume":"219","author":"B Halliwell","year":"1984","unstructured":"Halliwell B, Gutteridge JMC (1984): Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219: 1\u201314.","journal-title":"Biochem J"},{"key":"19_CR9","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/S0140-6736(84)91886-5","volume":"1","author":"B Halliwell","year":"1984","unstructured":"Halliwell B, Gutteridge JMC (1984): Lipid peroxidation, oxygen radicals cell damage, and antioxidant therapy. Lancet 1: 1396\u20131397.","journal-title":"Lancet"},{"key":"19_CR10","first-page":"5","volume-title":"Bleomycin-detectable iron and phenanthroline-detectable copper in the cerebrospinal fluid of patients with neuronal ceroid-lipofuscinoses","author":"H Heiskala","year":"1988","unstructured":"Heiskala H, Gutteridge JMC, Westermarck T, Alanen T, Santavuori P (1988): Bleomycin-detectable iron and phenanthroline-detectable copper in the cerebrospinal fluid of patients with neuronal ceroid-lipofuscinoses. Am J Med Genet, Suppl 5: 193\u2013202."},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1126\/science.6505679","volume":"226","author":"GO Ivy","year":"1984","unstructured":"Ivy GO, Schottler F, Wenzel J, Baudry M, Lynch G (1984): Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain. Science 226: 985\u2013987.","journal-title":"Science"},{"key":"19_CR12","first-page":"5","volume-title":"Ovine ceroid-lipofuscinosis II: pathologic changes interperted in light of biochemical observations","author":"RD Jolly","year":"1988","unstructured":"Jolly RD, Shimada A, Craig AS, Kirkland KB, Palmer ND (1988): Ovine ceroid-lipofuscinosis II: pathologic changes interperted in light of biochemical observations. Am J Med Genet, Suppl 5: 159\u2013170."},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1111\/j.1651-2227.1988.tb10770.x","volume":"77","author":"A Kohlschutter","year":"1988","unstructured":"Kohlschutter A, Laabs R, Albani M (1988): Juvenile neuronal ceroid lipofuscinosis (JNCL): quantitative description of its clinical variability. Acta Paediatr Scand 77: 867\u2013872.","journal-title":"Acta Paediatr Scand"},{"key":"19_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0022-510X(86)90030-4","volume":"72","author":"T Krusius","year":"1986","unstructured":"Krusius T, Viitala J, Palo J, Maury CP (1986): Enrichment of high mannose-type glycans in nervous tissue glycoproteins in neuronal ceroid-lipofuscinosis. J Neurol Sci 72: 1\u201310.","journal-title":"J Neurol Sci"},{"key":"19_CR15","first-page":"5","volume-title":"Ovine ceroid-lipofuscinosis I: lipopigment composition is indicative of a lysosomal proteinosis","author":"DN Palmer","year":"1988","unstructured":"Palmer DN, Martinus RD, Barns G, Reeves RD, Jolly RD (1988): Ovine ceroid-lipofuscinosis I: lipopigment composition is indicative of a lysosomal proteinosis. Am J Med Genet, Suppl 5: 141\u2013158."},{"key":"19_CR16","first-page":"291","volume":"5","author":"M Philippart","year":"1988","unstructured":"Philippart M (1988): Diagnosis and treatment of typical and atypical forms of lipopigment storage disorders. Am J Med Genet, Suppl 5: 291\u2013298.","journal-title":"Suppl"},{"key":"19_CR17","first-page":"5","volume-title":"Oligosaccharyl diphosphodolichols in the ceroid-lipofuscinoses","author":"RK Pullarkat","year":"1988","unstructured":"Pullarkat RK, Kim KS, Sklower SL, Patel VK (1988): Oligosaccharyl diphosphodolichols in the ceroid-lipofuscinoses. Am J Med Genet, Suppl 5: 243\u2013252."},{"key":"19_CR18","doi-asserted-by":"crossref","unstructured":"Rapola J, Santavuori P, Heiskala H (1988): placental pathology and prenatal diagnosis of infantile type of neuronal ceroid-lipofuscinosis. Am J Med Genet Suppl 5: 99\u2013103.","DOI":"10.1002\/ajmg.1320310613"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/j.1600-0404.1985.tb03178.x","volume":"71","author":"P Santavuori","year":"1985","unstructured":"Santavuori P, Westermarck T, Rapola J, Lappi M, Moren R, Vuonnala U (1985): Antioxidant treatment in Spielmeyer-Sj\u00f4gren1s disease. Acta Neurol Scand 71: 136\u2013145.","journal-title":"Acta Neurol Scand"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S0387-7604(88)80075-5","volume":"10","author":"P Santavuori","year":"1988","unstructured":"Santavuori P (1988): Neuronal ceroid-lipofuscinoses in childhood. Brain Dev 10: 80\u201383.","journal-title":"Brain Dev"},{"key":"19_CR21","first-page":"5","volume-title":"Experience over 17 years with antioxidant treatment in Spielmeyer-Sj\u00f4gren disease","author":"P Santavuori","year":"1988","unstructured":"Santavuori P, Heiskala H, Westermarck T, Sainio K, Moren R (1988): Experience over 17 years with antioxidant treatment in Spielmeyer-Sj\u00f4gren disease. Am J Med Gen, Suppl 5: 265\u2013274."},{"key":"19_CR22","first-page":"281","volume-title":"Handbook of Free Radicals and Antioxidants in Biomedicine","author":"T Westermarck","year":"1988","unstructured":"Westermarck T, Santavuori P, Heiskala H (1988): Antioxidant therapy in neuronal ceroid lipofuscinoses (NCL). In: Handbook of Free Radicals and Antioxidants in Biomedicine, Vol II, CRC Pr\u00e8s Inc. Boca Baton, Eds Miquel J, Weber H & Quintanilha A, 281\u2013287."},{"key":"19_CR23","unstructured":"Westermarck T, Heiskala H, Johansson E, Lindh U, Santavuori P (1989): Iron, copper and zinc concentrations in mononuclear cells of patients with ceroid-lipofuscinoses. Elsevier (in press)"},{"key":"19_CR24","first-page":"5","volume-title":"Clinicopathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities","author":"KE Wisniewski","year":"1988","unstructured":"Wisniewski KE, Rapin I, Haney-Kieras J (1988): Clinicopathological variability in the childhood neuronal ceroid-lipofuscinoses and new observations on glycoprotein abnormalities. Am J Med Genet, Suppl 5: 27\u201346."},{"key":"19_CR25","first-page":"5","volume-title":"Dolichol and dolichyl phosphate in the neuronal ceroid-lipofuscinoses and other diseases","author":"LS Wolfe","year":"1988","unstructured":"Wolfe LS, Gauthier S, Haltia M, Palo J (1988): Dolichol and dolichyl phosphate in the neuronal ceroid-lipofuscinoses and other diseases. Am J Med Genet, Suppl 5: 233\u2013242."},{"key":"19_CR26","first-page":"588","volume-title":"The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome): in Vinken PJ, Bruyn GW (eds): \u201cHandbook of Clinical Neurology, Vol 10 (Leukodystrophies and Poliodystrophies). 11 Amsterdam","author":"W Zeman","year":"1970","unstructured":"Zeman W, Donohue S, Dyken P, Green J (1970): The neuronal ceroid-lipofuscinoses (Batten-Vogt syndrome): in Vinken PJ, Bruyn GW (eds): \u201cHandbook of Clinical Neurology, Vol 10 (Leukodystrophies and Poliodystrophies). 11 Amsterdam: North Holland Publ. Co., pp 588\u2013679."}],"container-title":["Advances in Experimental Medicine and Biology","Lipofuscin and Ceroid Pigments"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4899-5339-1_19","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,25]],"date-time":"2019-05-25T04:56:17Z","timestamp":1558760177000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4899-5339-1_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990]]},"ISBN":["9781489953414","9781489953391"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4899-5339-1_19","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"type":"print","value":"0065-2598"},{"type":"electronic","value":"2214-8019"}],"subject":[],"published":{"date-parts":[[1990]]}}}